Novavax (NVAX) Misses Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $10.00 +6.95%
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
ALZN, ASPU, USAU, More
Financial Fact:
General and administrative: 13.56M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.12), $0.03 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $6.53 million versus the consensus estimate of $10.59 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Investec Double Upgrades Supreme Industries (SI:IN) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
